# Embolx, Inc. – FDA Inspection, Jan 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/embolx-inc/7656bcf0-a41f-44b2-8331-fab503d5c150
Source feed: FDA_Inspections

> FDA inspection 1195728 of Embolx, Inc., January 19, 2023. Classification: Voluntary Action Indicated (VAI). 12 citations under 21 CFR parts 803 and 820. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195728
- Company Name: Embolx, Inc.
- Inspection Date: 2023-01-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Compliance: Devices
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 12

## Related Documents

- [FDA Inspection 1241795 - 2024-06-18](https://www.keypedia.com/records/fda_inspections/embolx-inc/8bbca1c9-641b-4a9b-b6b2-9c99b1b65240)
- FDA Inspection 1099935 - 2019-07-25

## Related Officers

- Jeffrey S. Buckser

Company: https://www.keypedia.com/companies/embolx-inc/3d06d7b2-85d3-4016-a1dd-ec60b5d4c00b

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7
